Table 5.
Immunization status with diphtheria and tetanus-containing vaccines among children born in 2006–2015 by survey site and age group — Ukraine, 2017
| Survey site | Diphtheria-tetanus-containing vaccine doses received | 2006–2015 cohorts, adjusted % (95% CI) | 2006–2010 cohorts, adjusted % (95% CI) | 2010–2015 cohorts, adjusted % (95% CI) |
|---|---|---|---|---|
| <3 doses | 27.6 (21.4–34.8) | 16.7 (11.4–23.8) | 38.6 (30.6–47.3) | |
| 0 doses | 11.4 (8.2–15.7) | 8.8 (5.8–13.0) | 14.0 (10.0–19.4) | |
| 1 dose | 6.2 (4.4–8.6) | 2.2 (1.4–3.5) | 10.2 (6.9–14.9) | |
| 2 doses | 10.0 (6.2–15.9) | 5.7 (2.8–11.3) | 14.4 (9.1–22.0) | |
| 3 doses | 17.8 (13.9–22.7) | 13.3 (9.4–18.4) | 22.4 (17.2–28.7) | |
| 4 doses | 38.1 (33.0–43.5) | 41.6 (35.6–47.8) | 34.7 (27.1–43.2) | |
| 5 doses | 16.4 (12.5–21.1) | 28.5 (21.8–36.4) | 4.2 (2.5–7.0) | |
| <3 doses | 21.0 (17.0–25.6) | 7.1 (3.8–12.9) | 35.8 (30.7–41.2) | |
| 0 doses | 5.9 (4.2–8.1) | 2.6 (1.2–5.6) | 9.4 (7.0–12.5) | |
| 1 dose | 7.1 (5.2–9.7) | 2.6 (1.2–5.6) | 12.0 (8.9–15.9) | |
| 2 doses | 8.0 (6.0–10.5) | 1.9 (0.9–4.1) | 14.4 (11.2–18.3) | |
| 3 doses | 18.5 (16.1–21.1) | 7.6 (5.3–10.8) | 30.1 (25.8–34.7) | |
| 4 doses | 29.3 (26.0–32.9) | 27.9 (23.4–32.9) | 30.8 (26.5–35.5) | |
| 5 doses | 31.2 (26.6–36.2) | 57.4 (49.7–64.7) | 3.3 (1.9–5.7) | |
| <3 doses | 22.6 (18.9–26.8) | 12.9 (9.4–17.4) | 32.4 (27.3–38.0) | |
| 0 doses | 9.7 (7.6–12.3) | 6.6 (4.9–8.9) | 12.8 (10.0–16.3) | |
| 1 dose | 6.2 (4.7–8.0) | 3.3 (1.8–5.8) | 9.1 (6.9–11.8) | |
| 2 doses | 6.7 (5.1–8.8) | 3.0 (1.9–4.7) | 10.5 (7.8–14.0) | |
| 3 doses | 16.8 (14.4–19.6) | 11.1 (8.3–14.5) | 22.6 (18.9–26.8) | |
| 4 doses | 36.8 (32.6–41.3) | 32.8 (28.0–37.9) | 40.9 (34.9–47.3) | |
| 5 doses | 23.8 (19.6–28.5) | 43.3 (35.5–51.4) | 4.1 (2.7–6.2) | |
| <3 doses | 13.5 (10.1–17.7) | 7.1 (5.1–9.8) | 19.8 (14.3–26.7) | |
| 0 doses | 5.7 (3.7–8.6) | 3.4 (1.8–6.1) | 8.0 (5.0–12.6) | |
| 1 dose | 1.9 (1.1–3.4) | 1.6 (0.8–3.0) | 2.2 (0.8–6.0) | |
| 2 doses | 5.9 (4.1–8.4) | 2.2 (1.2–3.8) | 9.6 (6.2–14.6) | |
| 3 doses | 19.0 (15.9–22.6) | 12.2 (8.4–17.4) | 25.9 (21.9–30.3) | |
| 4 doses | 44.4 (40.1–48.7) | 40.5 (35.2–46.0) | 48.2 (41.7–54.9) | |
| 5 doses | 23.1 (20.7–25.8) | 40.2 (34.8–45.9) | 6.1 (4.2–8.6) |
Note: Immunization data obtained from healthcare facility records; includes vaccine doses received by July-August 2017. All children selected for serosurvey are included, irrespective of their participation status. Recipients of ≥3 doses are considered to have received at least full primary series of diphtheria-tetanus-containing vaccines (DTCV); children in the older age group (those born in 2006–2010) are considered vaccinated age-appropriately if they have received five DTCV doses; children in the younger age group (those born in 2011–2015) are considered vaccinated age-appropriately if they have received ≥4 doses